Rapid Therapeutic Science Laboratories Inc (MINR) SEC filings

Rapid Therapeutic Science Laboratories Inc (MINR) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported MINR revenue for 2026-02-28 was $33.5K. Net income was -$9.4K. Revenue was up 28.8% from 2025-02-28 to 2026-02-28. MINR currently screens at market cap $47.1M. The MINR filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Rapid Therapeutic Science Laboratories Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.